Incidence and Characterisation of Persistent Pain in COVID-19 Survivors: A pan-European Concerted Action
- Funded by Novo Nordisk Foundation
- Total publications:1000 publications
Grant number: N/A
Grant search
Key facts
Disease
COVID-19start year
-99Known Financial Commitments (USD)
$1,279,584.1Funder
Novo Nordisk FoundationPrincipal Investigator
Professor Lars Arendt-NielsenResearch Location
N/ALead Research Institution
N/AResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Disease pathogenesis
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
Publicationslinked via Europe PMC
Last Updated:an hour ago
View all publications at Europe PMC